GenMont Biotech Incorporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 346.244 million compared to TWD 406.532 million a year ago. Operating income was TWD 77.623 million compared to TWD 122.205 million a year ago. Net income was TWD 57.451 million compared to TWD 158.019 million a year ago. Basic earnings per share from continuing operations was TWD 0.65 compared to TWD 1.11 a year ago. Basic earnings per share was TWD 0.65 compared to TWD 1.78 a year ago. Diluted earnings per share from continuing operations was TWD 0.64 compared to TWD 1.1 a year ago. Diluted earnings per share was TWD 0.64 compared to TWD 1.77 a year ago.